Navigation Links
Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
Date:10/10/2007

Effect of

Change in Accounting

Principle None $(4) None $(4)

The Agricultural Productivity segment consists primarily of crop protection products, the lawn-and-garden herbicide business, and the company's animal agricultural business.

Sales for Monsanto's Agricultural Productivity segment were $831 million for the fourth quarter of fiscal year 2007, or 3 percent lower compared with sales in the same period last year. Results in the quarter reflect lower sales from the company's selective chemistry business.

Sales for the segment were $3.6 billion for fiscal year 2007, or 9 percent higher compared with sales in the same period last year. Segment year-to-date sales benefited from higher sales of Roundup and other glyphosate-based herbicides globally primarily in the United States, Brazil, the Europe-Africa region, Asia, Canada and Argentina. Segment sales were partially offset by lower sales from the company's selective chemistry and dairy businesses.

Webcast Information

In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central time (9:30 a.m. eastern time) today. The call will focus on these results and future expectations. The call may also include a discussion of Monsanto's strategic initiatives, product performance and other matters related to the company's business.

Presentation slides and a simultaneous audio webcast of the conference call may be accessed by visiting the company's web site at http://www.monsanto.com/investor/. Visitors may need to download Windows Media Player(TM) prior to listening to the webcast. Following the live broadcast, a replay of the webcast will be available on the Monsanto web site for three weeks.

About Monsanto Company

Monsanto Company (NYSE:

SOURCE Monsanto
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Privacy, trust still the biggest barriers to electronic record sharing
2. Visions: Wade offers straight talk on e-medical records
3. Portal to e-records boosts care at Childrens Hospital
4. Yasnoff: Wisconsin should invest in health record bank
5. Doyle seeks $30M for e-medical record adoption
6. Impact of e-medical records will be felt at home
7. Epic responds to critics of electronic record installation
8. GE Healthcare launches hybrid electronic record
9. Careful with that electronic health record, Mr. Leavitt
10. Wisconsin companies reach deal on electronic health records
11. Tommy Thompson says capital needed for electronic health records

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire/--BlueMarbleEnergyCorp.announcedtodaythat...PDA)wererecentlyawarded$2millionbyWashingtonState,...ate/publicpartnershiptoconstructthestate,sfirstspe..., "Thisinvestmentwillsignificantlyspeedthedevelo...olnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."We...
(Date:11/24/2009)...dpointhasbeenmetforpatientswithadvanced-stage,orre.../PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ:...icalcompanyfocusedonendocrinetherapyandoncology,to...thitstargetedcytotoxicpeptideconjugate,AEZS-108(fo...ometrialcancer.Inapersonalizedhealthcareapproach,t...
(Date:11/24/2009).../PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: ...,today,announcedthatithassubmittedaMAAtotheEuropea...enzymereplacementtherapyindevelopment,forthetreatm...pplicationforvelaglucerasealfathathasbeensubmitted...a. , Basedonaglobalsupplyshortageofthecurrent...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc....cHealth,sExecutiveChairman,willpresentatthe21stAnn...Tuesday,December1,2009at10:00a.m.ET. ,, Toacces...ation,visittheInvestorRelationssectionofGenomicHea...Pleaseconnecttothewebsiteatleast15minutespriortoth...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
... Trusted LASIK Surgeons launc...tory service and website at www.TrustedLASIKSurge...ers seeking to improve their vision and find a hig...hances of attaining 20-20 vision. What sets the T...screening process ensuring that only those who are...
...TTLE, March 25 Trubion Pharmaceuticals, Inc. (Nas...on partner Wyeth Pharmaceuticals, a division of Wy...al trial of SBI-087, Trubion,s next generation CD2...pus erythematosus (SLE). Based on Trubion,s Small ..., SBI-087 is also being evaluated in a Phase 1 cli...
... DIEGO, March 25 David Koos, Chairman and CEO of ...OTC Bulletin Board: BMSN), told the editors of The... news weekly, that there is an excellent possibili..." in ,09 because of new business alliances and con... banking, stem cell research, or cell culturing." ...
Other Biology Technology:Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 2Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 3Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 4Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 5Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 6Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 7Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory 8Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE) 2Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE) 3Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview 2
(Date:11/23/2009)...C. The community-associated strain of the deadly ...nt to most common antibioticsposes a far greater h...ts way into hospitals, according to a study in the... , The new threat is easily picked up in fitnes...s increased the overall burden of MRSA within hosp...
(Date:11/23/2009)...ember 23, 2009 - The time of day matters to forest...per produced by a research team led by Professor M...,s vice-principal for research and colleagues in t...t. George campus. , Capitalizing on their prev... the research team examined how poplar trees use t...
(Date:11/23/2009)... -- More than 160 participants gathered this week ...URES INITIATIVE conference. This year,s topic, "Sy...ineers, and medical researchers to explore the eng...g the emerging field of synthetic biology. , Bon...Princeton University and this year,s conference ch...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 1Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 3Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 1Intralase 26amp 3B 238220 3BBladeless 26amp 3B 238221 3B Lasik Gains Popularity in the Raleigh NC Area 49584 2U S Army Increases Medical and Dental School Benefits 49582 1U S Army Increases Medical and Dental School Benefits 49582 2U S Army Increases Medical and Dental School Benefits 49582 3
...cal systems across the earth are being affected by... analysis of information not previously assembled ...ude earlier leafing of trees and plants over many ...and altitudes in the northern hemisphere; changes ...stralia; and shifting of the oceans plankton and f...
...veloped what they believe is the first new mechani...et used to treat all HIV patients, which could eve...archers at the University of Michigan used compute...hen confirmed in the lab that the compound does in... target for AIDS treatment. The protease is necess...
...nce widespread in the Pacific Northwests western l...pression, conifer and invasive plant encroachment,...as much as 99 percent of the oak communities histo...new technical report titled "Evaluation of Landsca...rie, Washington" outlines the findings of a study ...
Other Biology News:Warming climate is changing life on global scale, says new study 2Compound has potential for new class of AIDS drugs 2
Goat Anti-Human EML1 (K-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Aldolase A (N-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
BPAEC (B302-05) from European Collection of Cell Cultures (ECACC)
Goat Anti-Human RECK (F-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: